Literature DB >> 32550175

Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults.

Hanieh-Sadat Ejtahed1,2, Zahra Hoseini-Tavassol3, Shohre Khatami4, Mehrangiz Zangeneh5, Ava Behrouzi3, Sara Ahmadi Badi3, Arfa Moshiri6,7, Shirin Hasani-Ranjbar1, Ahmad-Reza Soroush1, Farzam Vaziri3, Abolfazl Fateh3, Mostafa Ghanei8, Saeid Bouzari9, Shahin Najar-Peerayeh10, Seyed Davar Siadat2,3, Bagher Larijani2.   

Abstract

BACKGROUND: Regarding the role of gut microbial dysbiosis in hyperglycemia, we aimed to compare the main gut bacterial composition among type 1 and type 2 diabetic patients and healthy non-diabetic adults.
METHODS: A total of 110 adult subjects (49 patients diagnosed with type 2 diabetes, 21 patients diagnosed with type 1 diabetes and 40 healthy persons) were included in this case-control study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method targeting bacterial 16S rRNA gene. Comparison between three groups was done using one-way analysis of variance.
RESULTS: The participants' mean age in the type 1 diabetes, type 2 diabetes and control groups was 35.4, 57.2 and 38.0 years, respectively. Higher level of Escherichia, Prevotella and Lactobacillus was observed in both type 1 and type 2 diabetic patients compared with the healthy group (P ˂0.001). In contrast, bacterial load of Bifidobacterium, Roseburia and Bacteroides was higher in healthy control group (P < 0.05). Faecalibacterium was significantly lower in type 1 diabetic patients compared with the other two groups (P ˂0.001). No significant difference was found in Akkermansia level among three groups.
CONCLUSIONS: Gut microbial alterations have been observed among patients suffering from type 1 and type 2 diabetes mellitus and healthy control adults. Butyrate producing genera including Roseburia and Faecalibacterium decreased while Escherichia, Prevotella and Lactobacillus increased in diabetic patients compared to healthy subjects. Modulating approaches of gut microbiota composition could be helpful in diabetes management. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Diabetes mellitus; Gut dysbiosis; Gut microbiota

Year:  2020        PMID: 32550175      PMCID: PMC7270240          DOI: 10.1007/s40200-020-00502-7

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  41 in total

1.  Neuromodulatory effect of microbiome on gut-brain axis; new target for obesity drugs.

Authors:  Hanieh-Sadat Ejtahed; Shirin Hasani-Ranjbar
Journal:  J Diabetes Metab Disord       Date:  2019-02-01

Review 2.  Roseburia spp.: a marker of health?

Authors:  Zohreh Tamanai-Shacoori; Imen Smida; Latifa Bousarghin; Olivier Loreal; Vincent Meuric; Shao Bing Fong; Martine Bonnaure-Mallet; Anne Jolivet-Gougeon
Journal:  Future Microbiol       Date:  2017-02       Impact factor: 3.165

3.  Gut microbiota profiling in Han Chinese with type 1 diabetes.

Authors:  Yun Huang; Si-Cheng Li; Ji Hu; Hai-Bin Ruan; He-Ming Guo; Hong-Hong Zhang; Xin Wang; Yu-Fang Pei; Yang Pan; Chen Fang
Journal:  Diabetes Res Clin Pract       Date:  2018-05-05       Impact factor: 5.602

Review 4.  Diabetes, obesity and gut microbiota.

Authors:  Amandine Everard; Patrice D Cani
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-02       Impact factor: 3.043

Review 5.  Human Microbiome as an Approach to Personalized Medicine.

Authors:  Hanieh-Sadat Ejtahed; Shirin Hasani-Ranjbar; Bagher Larijani
Journal:  Altern Ther Health Med       Date:  2017-11       Impact factor: 1.305

6.  Gastric acid reduction leads to an alteration in lower intestinal microflora.

Authors:  Takayuki Kanno; Takahiro Matsuki; Masashi Oka; Hirotoshi Utsunomiya; Kenichi Inada; Hirohito Magari; Izumi Inoue; Takao Maekita; Kazuki Ueda; Shotaro Enomoto; Mikitaka Iguchi; Kimihiko Yanaoka; Hideyuki Tamai; Shigeru Akimoto; Koji Nomoto; Ryuichiro Tanaka; Masao Ichinose
Journal:  Biochem Biophys Res Commun       Date:  2009-02-25       Impact factor: 3.575

7.  Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.

Authors:  Christopher T Brown; Austin G Davis-Richardson; Adriana Giongo; Kelsey A Gano; David B Crabb; Nabanita Mukherjee; George Casella; Jennifer C Drew; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Riitta Veijola; Tuula Simell; Olli Simell; Josef Neu; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Eric W Triplett
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

8.  Human gut microbiota changes reveal the progression of glucose intolerance.

Authors:  Xiuying Zhang; Dongqian Shen; Zhiwei Fang; Zhuye Jie; Xinmin Qiu; Chunfang Zhang; Yingli Chen; Linong Ji
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Fecal microbiota imbalance in Mexican children with type 1 diabetes.

Authors:  María Esther Mejía-León; Joseph F Petrosino; Nadim Jose Ajami; María Gloria Domínguez-Bello; Ana María Calderón de la Barca
Journal:  Sci Rep       Date:  2014-01-22       Impact factor: 4.379

10.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Authors:  Kristoffer Forslund; Falk Hildebrand; Trine Nielsen; Gwen Falony; Emmanuelle Le Chatelier; Shinichi Sunagawa; Edi Prifti; Sara Vieira-Silva; Valborg Gudmundsdottir; Helle K Pedersen; Manimozhiyan Arumugam; Karsten Kristiansen; Anita Yvonne Voigt; Henrik Vestergaard; Rajna Hercog; Paul Igor Costea; Jens Roat Kultima; Junhua Li; Torben Jørgensen; Florence Levenez; Joël Dore; H Bjørn Nielsen; Søren Brunak; Jeroen Raes; Torben Hansen; Jun Wang; S Dusko Ehrlich; Peer Bork; Oluf Pedersen
Journal:  Nature       Date:  2015-12-02       Impact factor: 49.962

View more
  7 in total

1.  The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes.

Authors:  Xue Zhao; Yiding Zhang; Ruixue Guo; Wei Yu; Fanliang Zhang; Feng Wu; Jin Shang
Journal:  J Diabetes Res       Date:  2020-11-11       Impact factor: 4.011

Review 2.  New Insights into Stroke Prevention and Treatment: Gut Microbiome.

Authors:  Linna Zhao; Liji Yang; Yuying Guo; Jie Xiao; Junping Zhang; Shixin Xu
Journal:  Cell Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.046

3.  Intestinal Microbiota Composition in Iranian Diabetic, Pre-diabetic and Healthy Individuals.

Authors:  Farahnaz Ghaemi; Abolfazl Fateh; Abbas Akhavan Sepahy; Mehrangiz Zangeneh; Mostafa Ghanei; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-08-31

Review 4.  Alzheimer's Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models.

Authors:  Maria Jose Carranza-Naval; Maria Vargas-Soria; Carmen Hierro-Bujalance; Gloria Baena-Nieto; Monica Garcia-Alloza; Carmen Infante-Garcia; Angel Del Marco
Journal:  Biomolecules       Date:  2021-02-10

Review 5.  Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia.

Authors:  Pirkko J Pussinen; Elisa Kopra; Milla Pietiäinen; Markku Lehto; Svetislav Zaric; Susanna Paju; Aino Salminen
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

6.  Assessment of fecal Akkermansia muciniphila in patients with osteoporosis and osteopenia: a pilot study.

Authors:  Shahrbanoo Keshavarz Azizi Raftar; Zahra Hoseini Tavassol; Meysam Amiri; Hanieh-Sadat Ejtahed; Mehrangiz Zangeneh; Sedigheh Sadeghi; Fatemeh Ashrafian; Arian Kariman; Shohreh Khatami; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2021-01-23

Review 7.  Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

Authors:  Ana López-Moreno; Inmaculada Acuña; Alfonso Torres-Sánchez; Ángel Ruiz-Moreno; Klara Cerk; Ana Rivas; Antonio Suárez; Mercedes Monteoliva-Sánchez; Margarita Aguilera
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.